Drug intelligence / Profile preview

Cyclo-Z

Development stage
Unknown
Lead developer
VA Office of Research & Development
Modality
Peptides, Small Molecules
Administration
Oral
01

Overview

Cyclo-Z is an investigational combination therapy developed by the VA Office of Research and Development for the treatment of type 2 diabetes mellitus. It consists of zinc and the cyclic dipeptide cyclo(histidyl-proline) (CHP), a naturally occurring metabolite of thyrotropin-releasing hormone. CHP acts as a zinc-binding ligand that facilitates the intestinal absorption and cellular uptake of zinc. Zinc is a critical cofactor for numerous enzymes involved in glucose metabolism and is essential for the proper synthesis, storage, and secretion of insulin. Furthermore, zinc has been shown to exert insulin-mimetic effects by activating the insulin receptor and downstream signaling pathways. By optimizing zinc homeostasis, Cyclo-Z aims to improve glycemic control and insulin sensitivity in patients with type 2 diabetes.

Other names
Cyclo(his-pro) plus zincCyclo-his-pro plus zincCHP-Zinc
02

Targets

INSR (Insulin receptor)

Beyond the preview

Go deeper on Cyclo-Z.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cyclo-Z.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call